Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma

被引:0
作者
Ling Deng
Jingyuan Sun
Xiaohui Chen
Li Liu
Dehua Wu
机构
[1] Nanfang Hospital,Department of Radiation Oncology
[2] Southern Medical University,Hepatology Unit and Department of Infectious Diseases
[3] Nanfang Hospital,undefined
[4] Southern Medical University,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词
Hepatocellular carcinoma; Sorafenib; Drug resistance; Nek2; β-Catenin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 98 条
[1]  
Chen W(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132
[2]  
Zheng R(2008)Sorafenib in Advanced Hepatocellular Carcinoma New England Journal of Medicine 359 378-390
[3]  
Baade PD(2018)Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway Digestive and Liver Disease 50 381-388
[4]  
Zhang S(2017)Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma Cancer Letters 398 12-21
[5]  
Zeng H(2016)Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma Cancer Letters 381 58-66
[6]  
Bray F(2018)Hepatocellular carcinoma The Lancet 391 1301-1314
[7]  
Llovet Josep M.(2014)Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival Journal of Surgical Oncology 110 828-838
[8]  
Ricci Sergio(2017)Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 Journal of Clinical Investigation 127 3075-3089
[9]  
Mazzaferro Vincenzo(2014)Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism Oncogene 34 1220-1230
[10]  
Hilgard Philip(undefined)undefined undefined undefined undefined-undefined